SCHEMBL7606818

SCHEMBL7606818

COc1ccc(C(=O)c2cc3ccccc3n2S(=O)(=O)c2ccccc2)c(OC)c1C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.52
LMNA P02545 1/20 0.52
MAPT P10636 1/20 0.52
NOD2 Q9HC29 4/20 0.48
NOD1 Q9Y239 4/20 0.48
HDAC3 O15379 5/20 0.46
HDAC4 P56524 5/20 0.46
HDAC1 Q13547 5/20 0.46
HDAC7 Q8WUI4 5/20 0.46
HDAC2 Q92769 5/20 0.46
HDAC10 Q969S8 5/20 0.46
HDAC11 Q96DB2 5/20 0.46
HDAC8 Q9BY41 5/20 0.46
HDAC6 Q9UBN7 5/20 0.46
HDAC9 Q9UKV0 5/20 0.46
HDAC5 Q9UQL6 5/20 0.46
ALOX5 P09917 1/20 0.44
CCR2 P41597 1/20 0.43
TUBB4A P04350 1/20 0.41
TUBB P07437 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7062747 0.90 HDAC3 (0.45) ALDH1A1LMNAMAPTNOD2NOD1
SCHEMBL7606948 0.86 ALDH1A1 (0.55) ALDH1A1LMNAMAPTNOD2NOD1
SCHEMBL7065133 0.86 NOD2 (0.56) ALDH1A1LMNAMAPTNOD2NOD1
SCHEMBL7067521 0.85 ALDH1A1 (0.54) ALDH1A1LMNAMAPTNOD2NOD1
SCHEMBL7065741 0.85 LMNA (0.58) ALDH1A1LMNAMAPTNOD2NOD1
SCHEMBL7066118 0.84 ALDH1A1 (0.53) ALDH1A1LMNAMAPTNOD2NOD1
SCHEMBL7063873 0.84 ALDH1A1 (0.57) ALDH1A1LMNAMAPTNOD2NOD1
SCHEMBL7063612 0.83 HDAC3 (0.54) ALDH1A1LMNAMAPTNOD2NOD1
SCHEMBL7066962 0.83 HDAC3 (0.54) ALDH1A1LMNAMAPTNOD2NOD1
SCHEMBL7065222 0.83 ALDH1A1 (0.54) ALDH1A1LMNAMAPTNOD2NOD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020091124-A1 2-acyl indole derivatives and their use as antitumor agents BECKERS THOMAS (DE) 2002-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020091124-A1 2-acyl indole derivatives and their use as antitumor agents IDO1, IDO2, INMT ALDH1A1 789/4885LMNA 3780/4885MAPT 223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.